@article{article, title  = {{12670 CHAMPAIN Study: Initial Results From A Phase II Study Of Efficacy, Safety And Tolerability Of Modified-release Hydrocortisones: Chronocort® (Efmody®) Versus Plenadren®, In Primary Adrenal Insufficiency}},

 publisher = {{The Endocrine Society}},

 url = {{http://dx.doi.org/10.1210/jendso/bvae163.132 }},

 year = {{2024}},

 month = {{10}},

 author = {{Prete A and Theiler-Schwetz V and Arlt W and Oana Chifu I and Harbeck B and Napier C and Newell-Price JDC and Rees A and Reisch N and Karl Stalla G and Aslam N et al}},

 doi = {{10.1210/jendso/bvae163.132}},

 volume = {{8}},

 journal = {{Journal of the Endocrine Society}},

 issue = {{Supplement_1}},

 note = {{Accessed on 2024/12/22}}}